- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x TCL: TRICLOSAN(Non-covalent)
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NAP.2: 27 residues within 4Å:- Chain A: G.34, I.35, A.36, S.40, I.41, R.61, K.62, S.65, I.86, D.87, V.88, S.114, I.115, A.116, I.141, T.166, T.167, Y.168, K.185, A.211, G.212, P.213, I.214, T.216, L.217, S.218
- Ligands: TCL.1
22 PLIP interactions:22 interactions with chain A- Hydrophobic interactions: A:I.41, A:Y.168, A:Y.168
- Hydrogen bonds: A:G.34, A:A.36, A:I.41, A:R.61, A:R.61, A:K.62, A:S.65, A:D.87, A:V.88, A:I.115, A:K.185, A:I.214, A:I.214, A:L.217, A:S.218, A:S.218
- Salt bridges: A:R.61, A:K.62
- pi-Cation interactions: A:R.61
NAP.3: 29 residues within 4Å:- Chain B: G.34, I.35, A.36, S.40, I.41, R.61, K.62, S.65, I.86, D.87, V.88, S.114, I.115, A.116, F.117, I.141, T.166, T.167, Y.168, K.185, A.211, G.212, P.213, I.214, T.216, L.217, S.218, F.225
- Ligands: TCL.4
21 PLIP interactions:21 interactions with chain B- Hydrophobic interactions: B:I.41, B:Y.168, B:A.211
- Hydrogen bonds: B:G.34, B:I.41, B:R.61, B:R.61, B:S.65, B:D.87, B:V.88, B:Q.89, B:I.115, B:A.116, B:K.185, B:I.214, B:I.214, B:S.218
- Water bridges: B:L.217
- Salt bridges: B:R.61, B:K.62
- pi-Cation interactions: B:R.61
NAP.5: 28 residues within 4Å:- Chain C: G.34, I.35, A.36, S.40, I.41, R.61, K.62, S.65, I.86, D.87, V.88, S.114, I.115, A.116, I.141, T.166, T.167, Y.168, K.185, A.211, G.212, P.213, I.214, T.216, L.217, S.218, F.225
- Ligands: TCL.6
17 PLIP interactions:17 interactions with chain C- Hydrophobic interactions: C:Y.168, C:Y.168
- Hydrogen bonds: C:G.34, C:I.41, C:R.61, C:S.65, C:D.87, C:V.88, C:I.115, C:A.116, C:K.185, C:I.214, C:I.214, C:T.216, C:S.218
- Salt bridges: C:R.61, C:K.62
NAP.8: 27 residues within 4Å:- Chain D: G.34, I.35, A.36, S.40, I.41, R.61, K.62, I.86, D.87, V.88, S.114, I.115, A.116, F.117, I.141, T.166, T.167, Y.168, K.185, A.211, G.212, P.213, I.214, T.216, L.217, S.218
- Ligands: TCL.7
18 PLIP interactions:18 interactions with chain D- Hydrophobic interactions: D:I.41, D:Y.168
- Hydrogen bonds: D:G.34, D:I.41, D:R.61, D:K.62, D:S.65, D:D.87, D:V.88, D:S.114, D:I.115, D:K.185, D:I.214, D:I.214, D:S.218
- Salt bridges: D:R.61, D:K.62
- pi-Cation interactions: D:R.61
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schiebel, J. et al., Staphylococcus Aureus Fabi: Inhibition, Substrate Recognition and Potential Implications for in Vivo Essentiality. Structure (2012)
- Release Date
- 2012-05-09
- Peptides
- ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADPH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x TCL: TRICLOSAN(Non-covalent)
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schiebel, J. et al., Staphylococcus Aureus Fabi: Inhibition, Substrate Recognition and Potential Implications for in Vivo Essentiality. Structure (2012)
- Release Date
- 2012-05-09
- Peptides
- ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADPH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D